دورية أكاديمية
Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia
| العنوان: | Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia |
|---|---|
| المؤلفون: | Makimoto, Go, Misawa, Mahito, Maeda, Yoshinobu, Kiura, Katsuyuki |
| المصدر: | Respiratory Medicine Case Reports |
| بيانات النشر: | Elsevier |
| سنة النشر: | 2022 |
| المجموعة: | Okayama University Scientific Achievement Repository / 岡山大学学術成果リポジトリ |
| مصطلحات موضوعية: | Chronic myeloid leukemia, Chylothorax, Dasatinib |
| الوصف: | Dasatinib, an effective second-generation tyrosine kinase inhibitor, is used to treat breakpoint cluster region-Ableson-positive chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphocytic leukemia. One common adverse event associated with dasatinib use is fluid retention, including pleural effusion. Chylothorax, however, is a rare adverse event. Although the precise mechanism of dasatinib-induced chylothorax is unclear, almost all cases involve right or bilateral chylothorax, and mostly occur within 5 years of dasatinib initiation. Here, we report a rare case of a patient with dasatinib-induced massive left chylothorax 10 years after dasatinib initiation, which improved after dasatinib termination and a switch to bosutinib. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2213-0071 |
| العلاقة: | info:pmid/35585905; https://ousar.lib.okayama-u.ac.jp/files/public/6/63708/20220621164238889332/fulltext.pdfTest; https://ousar.lib.okayama-u.ac.jp/63708Test |
| الإتاحة: | https://doi.org/10.1016/j.rmcr.2022.101662Test https://ousar.lib.okayama-u.ac.jp/files/public/6/63708/20220621164238889332/fulltext.pdfTest https://ousar.lib.okayama-u.ac.jp/63708Test |
| حقوق: | © 2022 The Authors. |
| رقم الانضمام: | edsbas.8FDDCA03 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 22130071 |
|---|